Flyer

Health Science Journal

  • ISSN: 1791-809X
  • Journal h-index: 61
  • Journal CiteScore: 17.30
  • Journal Impact Factor: 18.23
  • Average acceptance to publication time (5-7 days)
  • Average article processing time (30-45 days) Less than 5 volumes 30 days
    8 - 9 volumes 40 days
    10 and more volumes 45 days
Awards Nomination 20+ Million Readerbase
Indexed In
  • Genamics JournalSeek
  • China National Knowledge Infrastructure (CNKI)
  • CiteFactor
  • CINAHL Complete
  • Scimago
  • Electronic Journals Library
  • Directory of Research Journal Indexing (DRJI)
  • EMCare
  • OCLC- WorldCat
  • MIAR
  • University Grants Commission
  • Geneva Foundation for Medical Education and Research
  • Euro Pub
  • Google Scholar
  • SHERPA ROMEO
  • Secret Search Engine Labs
Share This Page

Milk, parmesan and mozzarella: a case report of Burnett's syndrome

Congresso Regionale Fadoi Campania 2023 Cdc 231 (proceedings of XXII Congress of Fadoi Campania)
22 September 2023, Italy

Coronella C, Fortunato F, Iannuzzi R, Cannavale A, Pannone B, Delli Paoli V, Gargiulo F, Laccetti M

UOC Medicina Interna 1 AORN â??Cardarelliâ? Napoli

Scientific Tracks Abstracts: Health Sci J

Abstract:

Background Milk-alkali syndrome (MAS) is characterized by three elements: elevated blood calcium levels, metabolic alkalosis and progressive worsening of renal insufficiency. MAS is due to an high ingestion of products rich in calcium or even the use of antacids due to the presence of dyspepsia or drugs indicated in the treatment of osteoporosis. Case history We are describing the case of a 72 years old patient who is hospitalized accompanied by his wife due to slow speech and onset of dysarthria. He suffered from diabetes mellitus type 2, CKD, glaucoma, previous acute myocardial infraction. Home therapy with enalapril 5 mg, carvedilolo 6.25 two times a day, plavix, pantoprazole, omega 3, metformina, febuxostat 80, atorvastatin, vitamin D3 1000 one pill a day, empaglifozin 10 mg. At the moment of the visit the patient was soporous, awakenable with pain stimulus and was able to carry out simple orders. Esams routine underlined a severe hyperkalaemia 14.5 mg/dl with a severe kidney failure (creatinine 6.5 mg/dl and azotemia 328 mg/dl). Practiced U/I skull CT with negative result for acute events. On the advice of the nephrologist consultant, the patient underwent therapy with zoledronic acid and subsequent dialysis treatment. All exams are then done to identify the cause of the hyperkalaemia.